N@N

IEI, TLH, BSV, TIPZ, PLW, PCRX Are Seasonally Ripe To Go Up In the Next Five Weeks

_{//stocks-investing.news-articles.net/content/201 .. onally-ripe-to-go-up-in-the-next-five-weeks.html}
^{Published in Stocks and Investing on Monday, September 12th 2016 at 1:45 GMT by WOPRAI}  

September 12, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of iShares Barclays 3-7 Year Treasury Bond Fund (NYSE:IEI), iShares Barclays 10-20 Year Treasury Bond Fund (NYSE:TLH), Vanguard Short-Term Bond ETF (NYSE:BSV), PIMCO ETF Trust (NYSE:TIPZ), PowerShares 1-30 Laddered Treasury Portfolio (NYSE:PLW), Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  IEI     iShares Barclays 3-7 Year Treasury Bond Fund  0.77%            88.89% (8 of 9)      Friday, September 30th 2016
  TLH     iShares Barclays 10-20 Year Treasury Bond Fund  1.67%            88.89% (8 of 9)      Monday, October 3rd 2016
  BSV     Vanguard Short-Term Bond ETF     0.23%            88.89% (8 of 9)      Friday, September 23rd 2016
  TIPZ    PIMCO ETF Trust                  1.50%            100.00% (7 of 7)     Tuesday, October 25th 2016
  PLW     PowerShares 1-30 Laddered Treasury Portfolio  1.22%            100.00% (8 of 8)     Tuesday, September 27th 2016
  PCRX    Pacira Pharmaceuticals Inc.      6.21%            100.00% (5 of 5)     Friday, September 16th 2016

iShares Barclays 10-20 Year Treasury Bond Fund (NYSE:TLH) - iShares Trust iShare Lehman 1020 Year Treasury Bond Fund.

Vanguard Short-Term Bond ETF (NYSE:BSV) - Vanguard ShortTerm Bond ETF.

PIMCO ETF Trust (NYSE:TIPZ) - Pimco Broad U.S. Tips Index Fund.

PowerShares 1-30 Laddered Treasury Portfolio (NYSE:PLW) - PowerShares Exchange Traded Fund Trust II.

Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) - Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. Its lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia. The company also markets DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a life-threatening complication of lymphoma, a cancer of the immune system. Its development pipeline comprises DepoMeloxicam, a long-acting non-steroidal anti-inflammatory drug, which is in preclinical development for the treatment of acute postsurgical pain; and DepoTranexamic Acid, a pre-clinical development product for the treatment or prevention of excessive blood loss during surgery by promoting hemostasis. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net